CES1 and colorectal carcinoma: Furthermore, the metastasis-prone CRC consensus molecular subtype (CMS)4 exhibited higher CES1 expression and NF-κB activity, which were linked to inflammation, obesity, the epithelial-to-mesenchymal transition (EMT), and poorer clinical outcomes for CRC patients (Capece et al., 2021).